Correlation between Cytology and Cystoscopy in the Follow-Up of Patients with
Bladder Tumours

Jm, Dubernard; Devonec, M; Amiel, J.; Bouvier, Raymonde; B, Fontanière; Faucon, M

doi:10.1159/000473467

Cited by 9 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Negative cytology was found in 98% of controls and 94% of bladder tumour patients with negative cystoscopies. However, only 36% of positive cystoscopies in the same series were identified by cytology (Dubernard et al, 1982). Wajsman et al (1975) studied urinary FDPs in 66 patients with bladder tumours.…”

mentioning

confidence: 99%

Urinary Fibrin/Fibrinogen Degradation Products in Transitional Cell Carcinoma of the Bladder

Ewing¹,

Tate²,

Hetherington³

1987

British Journal of Urology

View full text Add to dashboard Cite

Urinary fibrin/fibrinogen degradation products (FDPs) were measured in 210 specimens from 174 patients with newly or previously diagnosed transitional cell carcinoma of the bladder. They were detected in 94% of patients with deeply invasive bladder tumours (pT2-4) compared with 17% of superficial tumours. Microalbuminuria (greater than 50 micrograms/g creatinine) was also found in 80% of patients with pT2-4 lesions. Both were compared with urine cytology. Urinary FDPs are markers of bladder tumour invasion. Our results suggest that urinary FDPs are not of value in screening for the presence of bladder neoplasia but their role may be in following patients with superficial bladder tumours to detect those tumours which become invasive. The mode of excretion of the FDPs in the urine is discussed.

show abstract

mentioning

confidence: 99%